Tags

Type your tag names separated by a space and hit enter

Orthopaedic Management of Gout.

Abstract

Gout is characterized by the deposition of monosodium urate crystals in patients with chronically elevated blood levels of uric acid. It is the most common form of inflammatory arthritis in the United States and is often comorbid with hypertension, obesity, and chronic kidney disease. Initial presentation is usually an acutely warm, swollen joint, most commonly the first metatarsophalangeal joint, but a variety of locations may be affected. The main treatment for gout is medical management of acute inflammation and chronic uric acid levels, but surgical treatment may be indicated in cases of damage to the surrounding soft tissue, concomitant septic arthritis, symptomatic cartilage loss, or neurologic deficits. Based on the literature to date, gout does not seem to independently affect outcomes after total hip, knee, and ankle arthroplasty, but associated comorbidities affecting outcomes in these patients should be considered.

Authors+Show Affiliations

From the Department of Orthopaedic Surgery, Louisiana State University Health Sciences Center, New Orleans, LA (Dr. Cohen-Rosenblum); the Texas Orthopedics; Affiliate Faculty, Department of Surgery and Perioperative Care, Dell Medical School, The University of Texas, Austin, TX (Dr. Somogyi); the Department of Orthopaedic Surgery and Rehabilitation, University of Chicago Medicine, Chicago, IL (Dr. Hynes); and the Department of Medicine, Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, LA (Dr. Guevara).No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

36346841

Citation

Cohen-Rosenblum, Anna R., et al. "Orthopaedic Management of Gout." Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews, vol. 6, no. 11, 2022.
Cohen-Rosenblum AR, Somogyi JR, Hynes KK, et al. Orthopaedic Management of Gout. J Am Acad Orthop Surg Glob Res Rev. 2022;6(11).
Cohen-Rosenblum, A. R., Somogyi, J. R., Hynes, K. K., & Guevara, M. E. (2022). Orthopaedic Management of Gout. Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews, 6(11). https://doi.org/10.5435/JAAOSGlobal-D-22-00216
Cohen-Rosenblum AR, et al. Orthopaedic Management of Gout. J Am Acad Orthop Surg Glob Res Rev. 2022 11 1;6(11) PubMed PMID: 36346841.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Orthopaedic Management of Gout. AU - Cohen-Rosenblum,Anna R, AU - Somogyi,Jason R, AU - Hynes,Kelly K, AU - Guevara,Myriam E, Y1 - 2022/11/08/ PY - 2022/08/08/received PY - 2022/08/14/accepted PY - 2022/11/8/entrez PY - 2022/11/9/pubmed PY - 2022/11/11/medline JF - Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews JO - J Am Acad Orthop Surg Glob Res Rev VL - 6 IS - 11 N2 - Gout is characterized by the deposition of monosodium urate crystals in patients with chronically elevated blood levels of uric acid. It is the most common form of inflammatory arthritis in the United States and is often comorbid with hypertension, obesity, and chronic kidney disease. Initial presentation is usually an acutely warm, swollen joint, most commonly the first metatarsophalangeal joint, but a variety of locations may be affected. The main treatment for gout is medical management of acute inflammation and chronic uric acid levels, but surgical treatment may be indicated in cases of damage to the surrounding soft tissue, concomitant septic arthritis, symptomatic cartilage loss, or neurologic deficits. Based on the literature to date, gout does not seem to independently affect outcomes after total hip, knee, and ankle arthroplasty, but associated comorbidities affecting outcomes in these patients should be considered. SN - 2474-7661 UR - https://www.unboundmedicine.com/medline/citation/36346841/Orthopaedic_Management_of_Gout_ DB - PRIME DP - Unbound Medicine ER -